ctDNA Identifies CRC Patients Who Benefit From Adjuvant Therapy ctDNA Identifies CRC Patients Who Benefit From Adjuvant Therapy

A blood test that measures circulating tumor DNA can identify patients with colorectal cancer who may derive the most benefit from adjuvant chemotherapy.Medscape Medical News
Source: Medscape Pathology Headlines - Category: Pathology Tags: Hematology-Oncology News Source Type: news